Christine Chen

1.1k total citations
16 papers, 776 citations indexed

About

Christine Chen is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Christine Chen has authored 16 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Hematology. Recurrent topics in Christine Chen's work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Cancer Treatment and Pharmacology (3 papers). Christine Chen is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers) and Cancer Treatment and Pharmacology (3 papers). Christine Chen collaborates with scholars based in United States, Canada and Australia. Christine Chen's co-authors include Zhinuan Yu, Robert Knight, Marta Olesnyckyj, Meletios Α. Dimopoulos, D. Weber, Michel Attal, Donna Reece, Maria Teresa Petrucci, Rubén Niesvizky and Edward A. Stadtmauer and has published in prestigious journals such as Journal of the American College of Cardiology, British journal of surgery and Leukemia.

In The Last Decade

Christine Chen

15 papers receiving 754 citations

Peers

Countries citing papers authored by Christine Chen

Since Specialization

Citations

This map shows the geographic impact of Christine Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Chen more than expected).

Fields of papers citing papers by Christine Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Chen. The network helps show where Christine Chen may publish in the future.

Co-authorship network of co-authors of Christine Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Chen. A scholar is included among the top collaborators of Christine Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Chen. Christine Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Development of an Innovative Decision-Aid to Better Align Patients’ Implantable Cardioverter Defibrillator Shock Status With Goals of Care 2025 ·Circulation Cardiovascular Quality and Outcomes ·Christine Chen, (unknown), (unknown), Kristin Alvarez, (unknown), Jingwen Zhang, (unknown), (unknown), (unknown), (unknown), Megan M. Kelly, (unknown)	2
2	Prognostic value of early post-treatment 18F-FDG PET/CT in diffuse large B-cell lymphoma patients receiving chimeric antigen receptor T-cell therapy 2025 ·Cancer Imaging ·Seyed Ali Mirshahvalad, Andrés Kohan, (unknown), Claudia Ortega, Ur Metser, David Hodgson, Robert Kridel, Christine Chen, Sita Bhella, (unknown), Patrick Veit‐Haibach	1
3	The Relationship Between ICD Knowledge and Goals of Care in a Diverse Patient Population 2025 ·Journal of Pain and Symptom Management ·(unknown), (unknown), (unknown), (unknown), (unknown), Nakul Patel, Christine Chen, Kristin Alvarez, (unknown), (unknown)	0
4	Increasing Knowledge about Implantable Cardioverter Defibrillators at the End of Life, an Effective Approach for Hospice Workers to Improve Patient Care 2024 ·Journal of Pain and Symptom Management ·(unknown), (unknown), (unknown), (unknown), Nakul Patel, (unknown), Christine Chen, (unknown)	2
5	How to Build an Antiracist Cardiovascular Culture, Community, and Profession 2021 ·Journal of the American College of Cardiology ·(unknown), (unknown), David E. Winchester, Christine Chen, (unknown)	2
6	Evaluating the Effect of Concussion-Education Programs on Intent to Report Concussion in High School Football 2021 ·Journal of Athletic Training ·Daniel H. Daneshvar, Maya Yutsis, Christine M. Baugh, Roy Pea, Shelley Goldman, Gerald A. Grant, Jamshid Ghajar, Lee Sanders, Christine Chen, (unknown), (unknown), Ross Zafonte, (unknown)	16
7	Athlete Enjoyment of Prior Education Moderates change in Concussion-Reporting Intention after Interactive Education 2021 ·INQUIRY The Journal of Health Care Organization Provision and Financing ·Daniel H. Daneshvar, Christine M. Baugh, Maya Yutsis, Roy Pea, Shelley Goldman, Gerald A. Grant, Robert C. Cantu, Lee Sanders, Christine Chen, (unknown), Ross Zafonte, (unknown)	5
8	Evaluation of a Routine Screening Program with Tuberculin Skin Testing on Rates of Detection of Latent Tuberculosis Infection and Prevention of Active Tuberculosis in Patients with Multiple Myeloma at a Canadian Cancer Centre 2020 ·Current Oncology ·Melissa Gitman, (unknown), Thắng Nguyễn, Christine Chen, Coleman Rotstein	2
9	Deep learning analysis of the primary tumour and the prediction of lymph node metastases in gastric cancer 2020 ·British journal of surgery ·Cheng Jin, Yuming Jiang, Heng Yu, (unknown), (unknown), Christine Chen, Qiang Yuan, Yanfeng Hu, (unknown), Zhiwei Zhou, (unknown), Ruijiang Li	48
10	Canadian Evidence-Based Guideline for the First-Line Treatment of Chronic Lymphocytic Leukemia 2018 ·Current Oncology ·Carolyn Owen, Alina S. Gerrie, Versha Banerji, Sarit Assouline, Christine Chen, Katherine Robinson, (unknown), Graeme Fraser	8
11	Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents 2014 ·Bone Marrow Transplantation ·Víctor H. Jiménez‐Zepeda, Donna Reece, Suzanne Trudel, Christine Chen, Rodger E. Tiedemann, Vishal Kukreti	35
12	Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma 2010 ·Haematologica ·Jean‐Luc Harousseau, Meletios Α. Dimopoulos, (unknown), Alessandro Corso, Christine Chen, Michel Attal, (unknown), Zhinuan Yu, Marta Olesnyckyj, (unknown), Robert Knight, D. Weber	82
13	Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma 2009 ·Leukemia ·Meletios Α. Dimopoulos, Christine Chen, Andrew Spencer, Rubén Niesvizky, Michel Attal, Edward A. Stadtmauer, Maria Teresa Petrucci, Zhinuan Yu, Marta Olesnyckyj, Jerome B. Zeldis, Robert Knight, D. Weber	271
14	Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial 2009 ·Leukemia ·Craig B. Reeder, Donna Reece, Vishal Kukreti, Christine Chen, Suzanne Trudel, Joseph G. Hentz, Brie N. Noble, Nicholas Pirooz, (unknown), J Píza, (unknown), Joseph Mıkhael, José F. Leis, P. Leif Bergsagel, Rafaël Fonseca, A. Keith Stewart	250
15	Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit 2008 ·Bone Marrow Transplantation ·Martina Trinkaus, Stephen E. Lapinsky, Michael Crump, Armand Keating, Donna Reece, Christine Chen, David Hallett, Norman Franke, Andrew Winter, Joseph Mıkhael	36
16	Intensification of the stem cell transplant induction regimen results in increased treatment-related mortality without improved outcome in multiple myeloma 1999 ·Bone Marrow Transplantation ·R. Abraham, Christine Chen, Richard Tsang, David Simpson, Cindy Murray, Melanie Davidson, J. Meharchand, (unknown), (unknown), Armand Keating, A. Keith Stewart	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact